Sacubitril/valsartan in COVID-19 patients: the need for trials

被引:11
|
作者
Acanfora, Domenico [1 ]
Ciccone, Marco Matteo [2 ]
Scicchitano, Pietro [2 ,3 ]
Acanfora, Chiara [1 ,4 ]
Casucci, Gerardo [1 ]
机构
[1] San Francesco Hosp, Unit Internal Med, Viale Europa 21, I-82037 Telese Terme, BN, Italy
[2] Univ Bari, Sch Med, Sect Cardiovasc Dis, Dept Emergency & Organ Transplantat, Bari, Italy
[3] Hosp F Perinei Altamura, Cardiol Unit, Bari, Italy
[4] Univ Aquila, Dept Biotechnol & Appl Clin Sci, Laquila, Italy
关键词
D O I
10.1093/ehjcvp/pvaa044
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:253 / 254
页数:2
相关论文
共 50 条
  • [21] COVID-19 in Patients With Rheumatic Diseases Is There a Need to Worry?
    Sachdeva, Sonali
    Manaktala, Pritika
    Malik, Faizan Ahmad
    Gupta, Udita
    Desai, Rupak
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2022, 28 (02) : E401 - E406
  • [22] Potential Uses of Sacubitril/Valsartan: Need for Data on Efficacy and Safety
    Fabien Huet
    Mariama Akodad
    Eran Kalmanovitch
    Jerome Adda
    Audrey Agullo
    Pascal Batistella
    Camille Roubille
    François Roubille
    American Journal of Cardiovascular Drugs, 2019, 19 : 1 - 10
  • [23] Enrollment of Pediatric Patients in COVID-19 Interventional Trials
    Ong, Mei-Sing
    Wu, Ann Chen
    Bourgeois, Florence T.
    JAMA HEALTH FORUM, 2023, 4 (11): : E233939
  • [24] Convalescent plasma to treat critically ill patients with COVID-19: framing the need for randomised clinical trials
    Manu Shankar-Hari
    Lise Estcourt
    Heli Harvala
    David Roberts
    David K. Menon
    Critical Care, 24
  • [25] Hydroxychloroquine in Patients with Rheumatic Disease Complicated by COVID-19: Clarifying Target Exposures and the Need for Clinical Trials
    Balevic, Stephen J.
    Hornik, Christoph P.
    Green, Thomas P.
    Clowse, Megan E. B.
    Gonzalez, Daniel
    Maharaj, Anil R.
    Schanberg, Laura E.
    Eudy, Amanda M.
    Swamy, Geeta K.
    Hughes, Brenna L.
    Cohen-Wolkowiez, Michael
    JOURNAL OF RHEUMATOLOGY, 2020, 47 (09) : 1424 - 1430
  • [26] Convalescent plasma to treat critically ill patients with COVID-19: framing the need for randomised clinical trials
    Shankar-Hari, Manu
    Estcourt, Lise
    Harvala, Heli
    Roberts, David
    Menon, David K.
    CRITICAL CARE, 2020, 24 (01)
  • [27] Potential Uses of Sacubitril/Valsartan: Need for Data on Efficacy and Safety
    Huet, Fabien
    Akodad, Mariama
    Kalmanovitch, Eran
    Adda, Jerome
    Agullo, Audrey
    Batistella, Pascal
    Roubille, Camille
    Roubille, Francois
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2019, 19 (01) : 1 - 10
  • [28] Ongoing Need for Clinical Trials and Contemporary End Points for Outpatient COVID-19
    Lee, Todd C.
    Boulware, David R.
    ANNALS OF INTERNAL MEDICINE, 2023, 176 (01) : 137 - 138
  • [29] Clinical trials in urological oncology: COVID-19 and the potential need for a new perspective
    Jiasian Teh
    Ellen O’Connor
    Jasamine Coles-Black
    Nathan Lawrentschuk
    World Journal of Urology, 2021, 39 : 3147 - 3149
  • [30] What Is the Best Drug to Treat COVID-19? The Need for Randomized Controlled Trials
    Ottaviani, Silvia
    Stebbing, Justin
    MED, 2020, 1 (01): : 9 - 10